Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maryam Etebari

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
BMC Cancer|October 11, 2015
Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulationGiulia De Falco, Maria Raffaella Ambrosio, Fabio Fuligni, et al.
Frontiers in Oncology|September 24, 2021
Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt LymphomaIrene Bagaloni, Axel Visani, Sara Biagiotti, et al.
Therapeutic Advances in Hematology|April 2, 2014
The evolution of clonality testing in the diagnosis and monitoring of hematological malignanciesAnna Gazzola, Claudia Mannu, Maura Rossi, et al.
Oncotarget|September 2, 2015
Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomasPier Paolo Piccaluga, Mohsen Navari, Giulia De Falco, et al.
Plos Pathogens|October 16, 2015
Distinct Viral and Mutational Spectrum of Endemic Burkitt LymphomaFrancesco Abate, Maria Raffaella Ambrosio, Lucia Mundo, et al.
Haematologica|November 2, 2018
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic targetMaria Rosaria Sapienza, Francesco Abate, Federica Melle, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
BMC Cancer|October 11, 2015
Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulationGiulia De Falco, Maria Raffaella Ambrosio, Fabio Fuligni, et al.
Frontiers in Oncology|September 24, 2021
Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt LymphomaIrene Bagaloni, Axel Visani, Sara Biagiotti, et al.
Therapeutic Advances in Hematology|April 2, 2014
The evolution of clonality testing in the diagnosis and monitoring of hematological malignanciesAnna Gazzola, Claudia Mannu, Maura Rossi, et al.
Oncotarget|September 2, 2015
Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomasPier Paolo Piccaluga, Mohsen Navari, Giulia De Falco, et al.
Plos Pathogens|October 16, 2015
Distinct Viral and Mutational Spectrum of Endemic Burkitt LymphomaFrancesco Abate, Maria Raffaella Ambrosio, Lucia Mundo, et al.
Haematologica|November 2, 2018
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic targetMaria Rosaria Sapienza, Francesco Abate, Federica Melle, et al.
Pageof 2